Jane Myers

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

David J. Straus, Carol S. Portlock, Jing Qin et al. · Blood · 2004 · 278 citations · Full text

Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.

David J. Straus, Jeffrey J. Gaynor, Jane Myers et al. · Journal of Clinical Oncology · 1990 · 163 citations

Prognostic Factors, Cancer Management, Pharmacotherapy +17

Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.

Joachim Yahalom, Jin‐Sook Ryu, David J. Straus et al. · Journal of Clinical Oncology · 1991 · 93 citations

Advanced-stage Hodgkin, Radiation Medicine, Health Sciences +15

Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized study

Joachim Yahalom, George Varsos, Zvi Fuks et al. · Cancer · 1993 · 88 citations

Treatment of advanced hodgkin's disease with chemotherapy and irradiation

David J. Straus, Jane Myers, Burton J. Lee et al. · The American Journal of Medicine · 1984 · 46 citations

Radiation Therapy, Advanced Hodgkin, Medicine +5